RadNet Price to Book Ratio 2012-2026 | RDNT
Historical price to book ratio values for RadNet (RDNT) over the last 10 years. The current price to book ratio for RadNet as of September 16, 2026 is 4.35.
| RadNet Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-16 | 75.78 | 4.28 | |
| 2026-06-30 | 61.67 | $17.73 | 3.48 |
| 2026-03-31 | 55.89 | $17.22 | 3.25 |
| 2025-12-31 | 71.35 | $17.52 | 4.07 |
| 2025-09-30 | 76.21 | $17.06 | 4.47 |
| 2025-06-30 | 56.91 | $15.71 | 3.62 |
| 2025-03-31 | 49.72 | $15.16 | 3.28 |
| 2024-12-31 | 69.84 | $15.31 | 4.56 |
| 2024-09-30 | 69.39 | $15.14 | 4.58 |
| 2024-06-30 | 58.92 | $14.77 | 3.99 |
| 2024-03-31 | 48.66 | $14.58 | 3.34 |
| 2023-12-31 | 34.77 | $11.97 | 2.91 |
| 2023-09-30 | 28.19 | $11.73 | 2.40 |
| 2023-06-30 | 32.62 | $11.25 | 2.90 |
| 2023-03-31 | 25.03 | $8.46 | 2.96 |
| 2022-12-31 | 18.83 | $8.51 | 2.21 |
| 2022-09-30 | 20.35 | $8.00 | 2.54 |
| 2022-06-30 | 17.28 | $7.88 | 2.19 |
| 2022-03-31 | 22.37 | $7.50 | 2.98 |
| 2021-12-31 | 30.11 | $6.46 | 4.66 |
| 2021-09-30 | 29.31 | $6.37 | 4.60 |
| 2021-06-30 | 33.69 | $5.68 | 5.93 |
| 2021-03-31 | 21.75 | $5.38 | 4.05 |
| 2020-12-31 | 19.57 | $5.00 | 3.91 |
| 2020-09-30 | 15.35 | $4.77 | 3.22 |
| 2020-06-30 | 15.87 | $4.52 | 3.51 |
| 2020-03-31 | 10.51 | $4.09 | 2.57 |
| 2019-12-31 | 20.30 | $4.63 | 4.38 |
| 2019-09-30 | 14.36 | $4.28 | 3.36 |
| 2019-06-30 | 13.79 | $4.24 | 3.25 |
| 2019-03-31 | 12.39 | $4.26 | 2.91 |
| 2018-12-31 | 10.17 | $4.09 | 2.49 |
| 2018-09-30 | 15.05 | $2.51 | 6.00 |
| 2018-06-30 | 15.00 | $2.59 | 5.80 |
| 2018-03-31 | 14.40 | $2.41 | 5.97 |
| 2017-12-31 | 10.10 | $1.47 | 6.89 |
| 2017-09-30 | 11.55 | $1.56 | 7.42 |
| 2017-06-30 | 7.75 | $1.35 | 5.76 |
| 2017-03-31 | 5.90 | $1.12 | 5.25 |
| 2016-12-31 | 6.45 | $1.12 | 5.77 |
| 2016-09-30 | 7.40 | $0.87 | 8.52 |
| 2016-06-30 | 5.34 | $0.80 | 6.71 |
| 2016-03-31 | 4.83 | $0.79 | 6.08 |
| 2015-12-31 | 6.18 | $0.79 | 7.84 |
| 2015-09-30 | 5.55 | $0.59 | 9.38 |
| 2015-06-30 | 6.69 | $0.27 | 24.38 |
| 2015-03-31 | 8.40 | $0.15 | 56.26 |
| 2014-12-31 | 8.54 | $0.18 | 47.50 |
| 2014-09-30 | 6.62 | $0.06 | 107.99 |
| 2014-06-30 | 6.63 | $-0.07 | -101.84 |
| 2014-03-31 | 2.84 | $-0.23 | -12.53 |
| 2013-12-31 | 1.67 | $0.06 | 30.31 |
| 2013-09-30 | 2.41 | $0.01 | 267.78 |
| 2013-06-30 | 2.65 | $0.12 | 21.51 |
| 2013-03-31 | 2.80 | $0.04 | 69.14 |
| 2012-12-31 | 2.53 | $-0.17 | -14.59 |
| 2012-09-30 | 2.78 | $-1.55 | -1.80 |
| 2012-06-30 | 2.66 | $-1.69 | -1.57 |
| 2012-03-31 | 3.18 | $-1.79 | -1.77 |
| 2011-12-31 | 2.13 | $-1.87 | -1.14 |
| 2011-09-30 | 2.44 | $-2.04 | -1.20 |
| 2011-06-30 | 4.40 | $-2.06 | -2.14 |
| 2011-03-31 | 3.50 | $-2.19 | -1.60 |
| 2010-12-31 | 2.82 | $-2.22 | -1.27 |
| 2010-09-30 | 2.40 | $-2.37 | -1.01 |
| 2010-06-30 | 2.37 | $-2.39 | -0.99 |
| 2010-03-31 | 3.18 | $-2.18 | -1.46 |
| 2009-12-31 | 2.04 | $-2.06 | -0.99 |
| 2009-09-30 | 2.59 | $-2.17 | -1.19 |
| 2009-06-30 | 2.25 | $-2.16 | -1.04 |
| 2009-03-31 | 1.24 | $-2.35 | -0.53 |
| 2008-12-31 | 3.35 | $-2.26 | -1.48 |
| 2008-09-30 | 4.01 | $-2.07 | -1.93 |
| 2008-06-30 | 6.20 | $-2.15 | -2.89 |
| 2008-03-31 | 7.04 | $-2.20 | -3.20 |
| 2007-12-31 | 10.15 | $-1.98 | -5.12 |
| 2007-09-30 | 8.90 | $-1.55 | -5.73 |
| 2007-06-30 | 9.53 | $-1.43 | -6.66 |
| 2007-03-31 | 5.71 | $-1.43 | -3.99 |
| 2006-12-31 | 4.62 | $-1.38 | -3.35 |
| 2006-10-31 | 5.14 | 0.00 | |
| 2006-09-30 | 5.44 | 0.00 | |
| 2006-07-31 | 3.40 | $-3.53 | -0.96 |
| 2006-06-30 | 3.50 | 0.00 | |
| 2006-04-30 | 2.52 | $-3.51 | -0.72 |
| 2006-03-31 | 1.00 | 0.00 | |
| 2006-01-31 | 0.68 | $-3.43 | -0.20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $6.069B | $2.040B |
| RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |